Up to 70,000 people in England who would have been eligible will be denied lecanemab.
David Thomas, Alzheimer's Research UK head of policy, predicted that the ruling will likely put the drug out of reach for "all but the most wealthy". He added: "If there's a licensed drug that is safe and effective, judged by the regulator, then that needs to be available to NHS patients, and not just those with the ability to pay."
Lecanemab, sold as Leqembi, is the world's first treatment proven to delay disease progression. Trials showed that it could slow cognitive decline by around five months.
It was yesterday approved by staff at the the Medicines and Healthcare products Regulatory Agency which decides whether drugs are safe and effective.
But the National Institute for Health and Care Excellence ruled its benefits were "too small to justify the costs" of making the treatment available on the NHS.
An expert committee found the high price of fortnightly infusions in hospital, intensive monitoring and "the relatively small benefits" meant that would not be a good use of taxpayer cash. The NHS bill for administering lecanemab and monitoring patients was estimated at £19,000 per person per year, not including the cost of the drug itself.
The price offered to the NHS by Japanese maker Eisai is confidential. Lecanemab is thought to cost £20,000 a patient a year in the US.
هذه القصة مأخوذة من طبعة August 23, 2024 من Daily Express.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة August 23, 2024 من Daily Express.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
AI Fayed Abuse Probe: Police Investigating More Than 5 People Over Enabling Claims
A POLICE investigation has been launched into "more than five people" who may have helped former Harrods boss Mohamed AI Fayed in his alleged campaign of sexual abuse.
LEEDS SPEED IT UP
A top finish to remember icon
Stokes sees value in long game after skipping IPL
BEN STOKES admits he is approaching the home straight in \"the back end of my career\" after opting to skip a big payday in the Indian Premier League.
Bazball now approaching moment of truth
COOK BELIEVES NEXT YEAR IS PIVOTAL FOR RISKY STYLE
Girl Guides to earn badges by using AI
GIRL Guides aged four to 18 will take part in artificial intelligence-based activities and badges, backed by Google, to help them gain digital skills.
'Game-changer' injection fights asthma attacks
First breakthrough in 50 years
Ruth Langsford jets off to jungle
RUTH Langsford has flown down under to join I'm A Celebrity's spin-off show at the end of a \"tough year\" for the presenter.
Conall comes barrelling in
UK flooded again by third named storm of season
"Transformative' scanner to aid faster, earlier diagnoses
A SCANNER that will speed up treatment for thousands of patients was unveiled yesterday by Science Secretary Peter Kyle.
Heading home in the ruins
THOUSANDS of families started to head home to southern Lebanon yesterday on the first day of the Israel-Hezbollah ceasefire. Civilians flooded back into the former war zone.